Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

NIH 2 OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Neuroblastoma 16 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Osteosarcoma 1 Neoplasms 1 Neoplasm, Residual 1 Leiomyosarcoma 1 Ganglioneuroblastoma 1 Bone Neoplasms 1

Interventions

Methotrexate 21 Ifosfamide 21 Cyclophosphamide 19 Doxorubicin 17 Cisplatin 14 Filgrastim 13 Gemcitabine 12 Etoposide 11 Leucovorin 9 apatinib 8 fludarabine 7 glucarpidase 6 Vincristine 6 Temozolomide 6 Radiotherapy 6 Nivolumab 6 Neoadjuvant Therapy 6 Drug Therapy 6 Carboplatin 6 regorafenib 5 cabozantinib 5 Zoledronic Acid 5 Topotecan 5 Mesna 5 Irinotecan 5 Granulocyte Colony-Stimulating Factor 5 Docetaxel 5 pembrolizumab 4 pegfilgrastim 4 camrelizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Osteosarcoma × dinutuximab × Clear all

NCT05400603 2025-12-26

Aflac-NBL-2002

Emory University

Phase 1 Recruiting

Neuroblastoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡